188 related articles for article (PubMed ID: 23486011)
1. Nitro-oleic acid protects against adriamycin-induced nephropathy in mice.
Liu S; Jia Z; Zhou L; Liu Y; Ling H; Zhou SF; Zhang A; Du Y; Guan G; Yang T
Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1533-41. PubMed ID: 23486011
[TBL] [Abstract][Full Text] [Related]
2. (Pro)renin receptor decoy peptide PRO20 protects against adriamycin-induced nephropathy by targeting the intrarenal renin-angiotensin system.
Luo R; Yang K; Wang F; Xu C; Yang T
Am J Physiol Renal Physiol; 2020 Nov; 319(5):F930-F940. PubMed ID: 32865014
[TBL] [Abstract][Full Text] [Related]
3. Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice.
Wang H; Liu H; Jia Z; Olsen C; Litwin S; Guan G; Yang T
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F754-62. PubMed ID: 20032118
[TBL] [Abstract][Full Text] [Related]
4. Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury.
Liu H; Jia Z; Soodvilai S; Guan G; Wang MH; Dong Z; Symons JD; Yang T
Am J Physiol Renal Physiol; 2008 Oct; 295(4):F942-9. PubMed ID: 18753300
[TBL] [Abstract][Full Text] [Related]
5. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
6. Nitrooleic acid protects against cisplatin nephropathy: role of COX-2/mPGES-1/PGE2 cascade.
Wang H; Jia Z; Sun J; Xu L; Zhao B; Yu K; Yang M; Yang T; Wang R
Mediators Inflamm; 2015; 2015():293474. PubMed ID: 25861160
[TBL] [Abstract][Full Text] [Related]
7. Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice.
Liu Y; Jia Z; Liu S; Downton M; Liu G; Du Y; Yang T
Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1555-62. PubMed ID: 23946292
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy.
Wang C; Li Q; Zhen J; Xu Y; Sun S
Int J Clin Exp Pathol; 2015; 8(12):15696-707. PubMed ID: 26884839
[TBL] [Abstract][Full Text] [Related]
9. Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3β acetylation.
Zhang X; Qu X; Sun YB; Caruana G; Bertram JF; Nikolic-Paterson DJ; Li J
PLoS One; 2013; 8(6):e67471. PubMed ID: 23840712
[TBL] [Abstract][Full Text] [Related]
10. Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis.
Takiue K; Sugiyama H; Inoue T; Morinaga H; Kikumoto Y; Kitagawa M; Kitamura S; Maeshima Y; Wang DH; Masuoka N; Ogino K; Makino H
BMC Nephrol; 2012 Mar; 13():14. PubMed ID: 22443450
[TBL] [Abstract][Full Text] [Related]
11. Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy.
Sun YB; Qu X; Zhang X; Caruana G; Bertram JF; Li J
PLoS One; 2013; 8(1):e55027. PubMed ID: 23359116
[TBL] [Abstract][Full Text] [Related]
12. Effects of previous physical training on adriamycin nephropathy and its relationship with endothelial lesions and angiogenesis in the renal cortex.
Faleiros CM; Francescato HD; Papoti M; Chaves L; Silva CG; Costa RS; Coimbra TM
Life Sci; 2017 Jan; 169():43-51. PubMed ID: 27884511
[TBL] [Abstract][Full Text] [Related]
13. A single amino acid substitution in PRKDC is a determinant of sensitivity to Adriamycin-induced renal injury in mouse.
Watanabe M; Takahashi Y; Hiura K; Nakano K; Okamura T; Sasaki H; Sasaki N
Biochem Biophys Res Commun; 2021 Jun; 556():121-126. PubMed ID: 33839407
[TBL] [Abstract][Full Text] [Related]
14. Renoprotective Effects of a Highly Selective A3 Adenosine Receptor Antagonist in a Mouse Model of Adriamycin-induced Nephropathy.
Min HS; Cha JJ; Kim K; Kim JE; Ghee JY; Kim H; Lee JE; Han JY; Jeong LS; Cha DR; Kang YS
J Korean Med Sci; 2016 Sep; 31(9):1403-12. PubMed ID: 27510383
[TBL] [Abstract][Full Text] [Related]
15. Progression of chronic adriamycin nephropathy in leukopenic rats.
Ginevri F; Trivelli A; Mutti A; Bergamaschi E; Fabbretti G; Callea F; Salvidio G; Altieri P; Perfumo F; Ghiggeri GM
Nephron; 1993; 63(1):79-88. PubMed ID: 8446256
[TBL] [Abstract][Full Text] [Related]
16. Ameliorating Effect of Gemigliptin on Renal Injury in Murine Adriamycin-Induced Nephropathy.
Kim DR; Lee SY; Kim JS; Kim YG; Moon JY; Lee SH; Lee TW; Ihm CG; Jeong KH
Biomed Res Int; 2017; 2017():7275109. PubMed ID: 28326327
[No Abstract] [Full Text] [Related]
17. Metallothionein over-expression in podocytes reduces adriamycin nephrotoxicity.
Yang L; Zheng S; Epstein PN
Free Radic Res; 2009 Feb; 43(2):174-82. PubMed ID: 19204870
[TBL] [Abstract][Full Text] [Related]
18. Role of CD8(+) cells in the progression of murine adriamycin nephropathy.
Wang Y; Wang YP; Tay YC; Harris DC
Kidney Int; 2001 Mar; 59(3):941-9. PubMed ID: 11231349
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats.
Zhang W; Li Q; Wang L; Yang X
Pediatr Nephrol; 2008 Dec; 23(12):2185-94. PubMed ID: 18791746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
